Ginkgo Bioworks
DNA
DNA
349 hedge funds and large institutions have $2.25B invested in Ginkgo Bioworks in 2023 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 139 increasing their positions, 58 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.03% more ownership
Funds ownership: 1.91% → 1.94% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less capital invested
Capital invested by funds: $2.25B → $2.25B (-$5.07M)
Holders
349
Holding in Top 10
2
Calls
$7.89M
Puts
$7.78M
Top Buyers
| 1 | +$24.9M | |
| 2 | +$15.9M | |
| 3 | +$15.9M | |
| 4 |
WF
Welch & Forbes
Boston,
Massachusetts
|
+$14M |
| 5 |
BlackRock
New York
|
+$8.99M |
Top Sellers
| 1 | -$60.1M | |
| 2 | -$7.03M | |
| 3 | -$6.92M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$4.54M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.67M |